IBDEI0OK ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10962,1,3,0)
 ;;=3^76519
 ;;^UTILITY(U,$J,358.3,10963,0)
 ;;=65420^^76^716^14^^^^1
 ;;^UTILITY(U,$J,358.3,10963,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10963,1,2,0)
 ;;=2^Pterygium Excision w/o Graft
 ;;^UTILITY(U,$J,358.3,10963,1,3,0)
 ;;=3^65420
 ;;^UTILITY(U,$J,358.3,10964,0)
 ;;=67028^^76^717^1^^^^1
 ;;^UTILITY(U,$J,358.3,10964,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10964,1,2,0)
 ;;=2^INTRAVITREAL EYE INJ-1 Eye/Unilateral
 ;;^UTILITY(U,$J,358.3,10964,1,3,0)
 ;;=3^67028
 ;;^UTILITY(U,$J,358.3,10965,0)
 ;;=J2778^^76^717^3^^^^1
 ;;^UTILITY(U,$J,358.3,10965,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10965,1,2,0)
 ;;=2^Ranibiz/LUCENTIS (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,10965,1,3,0)
 ;;=3^J2778
 ;;^UTILITY(U,$J,358.3,10966,0)
 ;;=C9257^^76^717^2^^^^1
 ;;^UTILITY(U,$J,358.3,10966,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10966,1,2,0)
 ;;=2^Bevaciz/AVASTIN (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,10966,1,3,0)
 ;;=3^C9257
 ;;^UTILITY(U,$J,358.3,10967,0)
 ;;=J0178^^76^717^4^^^^1
 ;;^UTILITY(U,$J,358.3,10967,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10967,1,2,0)
 ;;=2^Aflib/EYLEA (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,10967,1,3,0)
 ;;=3^J0178
 ;;^UTILITY(U,$J,358.3,10968,0)
 ;;=67028^^76^717^5^^^^1
 ;;^UTILITY(U,$J,358.3,10968,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10968,1,2,0)
 ;;=2^INTRAVITREAL EYE INJ-2 Eyes/Bilateral
 ;;^UTILITY(U,$J,358.3,10968,1,3,0)
 ;;=3^67028
 ;;^UTILITY(U,$J,358.3,10968,3,0)
 ;;=^357.33^1^1
 ;;^UTILITY(U,$J,358.3,10968,3,1,0)
 ;;=50
 ;;^UTILITY(U,$J,358.3,10969,0)
 ;;=J7312^^76^717^6^^^^1
 ;;^UTILITY(U,$J,358.3,10969,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10969,1,2,0)
 ;;=2^Dexameth Implant/OZURDEX
 ;;^UTILITY(U,$J,358.3,10969,1,3,0)
 ;;=3^J7312
 ;;^UTILITY(U,$J,358.3,10970,0)
 ;;=0509T^^76^718^1^^^^1
 ;;^UTILITY(U,$J,358.3,10970,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10970,1,2,0)
 ;;=2^ERG (pattern/pERG) w/ report
 ;;^UTILITY(U,$J,358.3,10970,1,3,0)
 ;;=3^0509T
 ;;^UTILITY(U,$J,358.3,10971,0)
 ;;=92273^^76^718^2^^^^1
 ;;^UTILITY(U,$J,358.3,10971,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10971,1,2,0)
 ;;=2^ERG (full field/ffERG) w/ report
 ;;^UTILITY(U,$J,358.3,10971,1,3,0)
 ;;=3^92273
 ;;^UTILITY(U,$J,358.3,10972,0)
 ;;=92274^^76^718^3^^^^1
 ;;^UTILITY(U,$J,358.3,10972,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10972,1,2,0)
 ;;=2^ERG (multifocal/mfERG) w/ report
 ;;^UTILITY(U,$J,358.3,10972,1,3,0)
 ;;=3^92274
 ;;^UTILITY(U,$J,358.3,10973,0)
 ;;=95930^^76^718^4^^^^1
 ;;^UTILITY(U,$J,358.3,10973,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10973,1,2,0)
 ;;=2^VEP,Checkerboard/Flash Test,CNS w/ report
 ;;^UTILITY(U,$J,358.3,10973,1,3,0)
 ;;=3^95930
 ;;^UTILITY(U,$J,358.3,10974,0)
 ;;=0333T^^76^718^5^^^^1
 ;;^UTILITY(U,$J,358.3,10974,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10974,1,2,0)
 ;;=2^VEP,Screen of Visual Acuity,automated w/ rpt
 ;;^UTILITY(U,$J,358.3,10974,1,3,0)
 ;;=3^0333T
 ;;^UTILITY(U,$J,358.3,10975,0)
 ;;=0464T^^76^718^6^^^^1
 ;;^UTILITY(U,$J,358.3,10975,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10975,1,2,0)
 ;;=2^VEP,Testing for Glaucoma w/ report
 ;;^UTILITY(U,$J,358.3,10975,1,3,0)
 ;;=3^0464T
 ;;^UTILITY(U,$J,358.3,10976,0)
 ;;=H54.3^^77^719^14
 ;;^UTILITY(U,$J,358.3,10976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10976,1,3,0)
 ;;=3^Visual Loss,Both Eyes,Unqualified
 ;;^UTILITY(U,$J,358.3,10976,1,4,0)
 ;;=4^H54.3
